Tislelizumab by BeiGene for Esophageal Squamous Cell Carcinoma (ESCC): Likelihood of Approval

Tislelizumab is under clinical development by BeiGene and currently in Pre-Registration for Esophageal Squamous Cell Carcinoma (ESCC).

CHEST Roundup: Diabetes in RA Patients Ups Risk of Interstitial Lung Disease

BOSTON — Some of the latest research advancements in the field of pulmonology presented at the CHEST 2024 annual meeting, hosted by the American College

October 15, 2024

Philips BiPAP recall now linked to 65 deaths, 952 injuries

UPDATE: June 28, 2024: Philips spokesperson Lu Yu wrote in an emailed statement that Philips does not recognize the number of reported injuries and deaths in

June 28, 2024

Andreessen Horowitz-backed startup lands $200M for AI-based drug discovery

Genesis Therapeutics, a startup using artificial intelligence to design small molecule drugs, has raised $200 million in Series B financing — one of the largest

August 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.